TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) Operating income 2016–2025
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA) annual operating income history from SEC filings — each fiscal year as reported.
$2.2BFY2025 · since FY2016: $2.2B → $2.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.2B | +811.9% |
| FY2024 | -$303.0M | -170.0% |
| FY2023 | $433.0M | +119.7% |
| FY2022 | -$2.2B | -228.0% |
| FY2021 | $1.7B | +148.0% |
| FY2020 | -$3.6B | -706.3% |
| FY2019 | -$443.0M | +72.9% |
| FY2018 | -$1.6B | +90.6% |
| FY2017 | -$17.5B | -911.7% |
| FY2016 | $2.2B | — |
Source: SEC XBRL filings · For reference only · Not investment advice